Corxel Bio
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A cell therapy biotech engineering immune cells to treat cancer and autoimmune disorders.
OncologyImmunology
Technology Platform
A cell engineering platform focused on enhancing the targeting, persistence, and safety of T cell and NK cell therapies for oncology.
Opportunities
Potential to develop a best-in-class cell therapy with superior efficacy in solid tumors, a major unmet need.
Risk Factors
High clinical development risk, complex manufacturing logistics, and potential for severe adverse events common to cell therapies.
Competitive Landscape
Enters a highly competitive global cell therapy arena with many companies pursuing similar engineering strategies for solid tumors.